Abstract The membrane bound matrix metalloproteinase MT1-MMP plays roles in modulating cell movement, independent of its abilities to remodel the extracellular matrix. Unlike many MMPs, MT1-MMP is activated in the Golgi prior to secretion by a pro-protein convertase, primarily furin. Regulation of the activation of pro-MT1-MMP has been methodically investigated, as altering the level of the active protein has broad implications in both activating other proMMPs, including pro-MMP-2, and many subsequent remodelling events. Our previous work in MCF-7 cells has demonstrated that modest, and not extremely high, levels of active MT1-MMP manifests into altered cell morphology and movement. At this low but optimal amount of MT1-MMP protein, changes to MT1-MMP levels are always mirrored by MMP-9 and pERK levels, and always opposite to MMP-2 levels. In this study, stable expression of the furin inhibitor α1-antitrypsin Portland (α1-PDX) in MDA-MB-231 cells increased overall MT1-MMP levels, but cells maintained a 21% proportion of pro-MT1-MMP. The increase in MT1-MMP was mirrored by increases in MMP-9 and pERK, but a decrease in MMP-2. These changes were associated with increased NF-κB transcription. In vitro analysis showed that α1-PDX decreased cell protrusions and migration, and this manifested as decreased tumourigenesis when examined in vivo using a chick CAM assay. 
Introduction
Matrix metalloproteinases (MMPs) are a family of zincdependent endopeptidases which function collectively to cleave all components of the extracellular matrix (ECM) (Bourboulia and Stetler-Stevenson 2010) . To maintain tissue integrity, the correct MMP family member must be present in its appropriate form (inactive, inhibited, or active) at the proper time and location (Egeblad and Werb 2002; Ellis and Crawford 2016; Nieuwesteeg et al. 2012 . Retaining proper MMP activity in tissues is achieved through regulation of MMP expression, pro-enzyme activation, and enzymatic activity through catalytic inhibition by their endogenous inhibitors, TIMPs and RECK (Visse and Nagase 2003) .
MMPs share common structural domains, including a catalytic domain and a pro-domain whose removal is needed for MMP activation. MT-MMPs also contain a transmembrane domain and a C-terminal cytoplasmic tail that is essential for localization and recycling (Seiki, 2003; Strongin, 2010) . Unlike secreted MMPs, which are activated extracellularly, MT-MMPs are activated intracellularly in the trans-Golgi by a protein-convertase-dependent mechanism (Sternlicht and Werb 2001) . Membrane type-1 matrix metalloproteinase (MT1-MMP, MMP-14) is a multifunctional cell-surface molecule whose functions extend beyond its classification as a protease (Egeblad and Werb 2002) . The pro-domain of MT1-MMP contains a furin cleavage motif, with trans-Golgi localized furin being a key component in its activation (Scamuffa et al. 2006; Seidah et al. 2008) .
Once active as a proteolytic enzyme, MT1-MMP is directly involved in the pericellular cleavage of several ECM glycoproteins and cell surface proteins. MT1-MMP proteolysis also activates other secreted pro-MMPs, most notably the gelatinases pro-MMP-2 and -9 (Toth et al. 2003) . Independent of proteolysis, the functions of MT1-MMP include activating intracellular signalling cascades, such as the MAPK pathway, resulting in changes in cell behaviour and function (Cepeda et al. 2016; Cepeda et al. 2017a; Pahwa et al. 2014) .
Taken together, the invasive potential of MT1-MMPexpressing cells is manifested by its degradation of ECM, its activation of the powerful gelatinase pro-MMP-2, and by signalling cascades (Itoh et al. 2001) . Paradoxically, during the activation of pro-MMP-2, two MT1-MMP molecules act with an inhibitory TIMP-2 molecule. This MT1-MMP/TIMP-2/ pro-MMP-2 complex principally activates pro-MMP-2, but has also been shown to activate secreted pro-MMP-9 (Toth et al. 2003) . Further, MT1-MMP and TIMP-2 form an additional complex that initiates the intracellular cascade of the MAPK pathway, leading to downstream phosphorylation of Extracellular-Signal-Regulated Kinase (ERK1/2) (Sounni et al. 2010) . Additionally, we recently showed that altering MT1-MMP activation, MMP catalytic activity, and ERK1/2 signalling (using furin inhibitor, BB94, and U0126, respectively) in MCF-7 and MDA-MB-231 cells resulted in inverse MMP-2 and -9 levels, regardless of treatment (Cepeda et al. 2017a) . This association was dependent on the cytoplasmic domain of MT1-MMP, where elevated levels of active MT1-MMP were mirrored by elevated pERK and MMP-9 levels, but lower MMP-2 levels, and resulted in cells that were more tumourigenic (Cepeda et al. 2017b) .
The effect of inhibiting MT1-MMP activation using furin inhibitors, including α1-antitrypsin Portland (Jean et al. 1998) , has been examined in various cancer cell lines.
However, the resulting effects on MT1-MMP levels, cell migration, and invasiveness have been confounding. In primary colorectal cancer cells, expression of α1-PDX increased pERK levels and cell migration, independent of MT1-MMP levels (Defilles et al. 2011) . In HeLa and osteosarcoma cells, α1-PDX reduced global MT1-MMP protein levels and decreased migration. However, neither study differentiated between the levels of the pro-nor active forms of MT1-MMP (Liu et al. 2014; Shi et al. 2015) . Bassi et al. (2001) also showed a decrease in invasiveness using three head and neck squamous cell carcinoma cell lines, however, the α1-PDXtransfected cells showed an increase in the amount of both pro-and active MT1-MMP protein levels. This increase in both active and pro-MT1-MMP was also observed in COS-1, HT-1080, and LoVo cells that were transfected with α1-PDX (Yana and Weiss 2000) . In vivo work has also demonstrated that α1-PDX can enhance the expression and activity of MT1-MMP in mouse joints (Lin et al. 2012) , despite α1-PDX's known role as a furin inhibitor that should lower active MT1-MMP levels.
To investigate inconsistent α1-PDX data and build on our previous findings where elevated MT1-MMP levels, together with elevated pERK and MMP-9 levels, increased tumour progression, here we examine the effect of stable expression of α1-PDX in MDA-MB-231 cells. To our knowledge, the effect of α1-PDX has never been examined through stable transfection in MDA-MB-231 cells. Similar to our previous findings, we show here that elevated active levels of MT1-MMP were associated with elevated pERK and MMP-9 levels, but decreased MMP-2 levels. However, these changes were associated with lower levels of NF-κB transcription and reduced in vitro cell migration/invasion, as well as reduced in vivo tumourigenesis in a chick chorioallantoic membrane (CAM) assay.
Materials and methods

Cell culture conditions and generation of stable cell lines
The human breast cancer cell line MDA-MB-231 (ATCC® HTB-26™) was cultured in Dulbecco's Modified Eagles (DMEM)/F-12 medium (Thermo Fisher) supplemented with 10% fetal bovine serum (FBS), 100 IU/mL penicillin, and 100 μg/mL streptomycin in a humidified incubator at 37°C with 5% CO 2 . Cells were maintained under 80% confluency and passaged accordingly using 0.25% Trypsin/EDTA. For generation of α1-PDX stables, cells seeded at a density of 5 × 10 5 cells/ mL and grown for 24 h were transfected with Alpha1-Antitrypsin Portland (α1-PDX, Jean et al. 1998 ) pRc/CMV vector using Lipofectamine 2000 (Thermo Fisher) according to manufacturer's instructions. Following transfection, cells were split 1:1000 and incubated in DMEM/FBS medium containing 1 mg/mL neomycin analog G418 (VWR). Individual colonies were selected after 4 weeks of incubation in selection medium and expanded to assay for α1-PDX expression by qPCR. The resulting clonal cells were called 231-PDX.
RNA extraction and quantitative real-time PCR
Parental MDA-MB-231 and 231-PDX cells seeded at a density of 1 × 10 6 cells/mL in DMEM/FBS were grown for 36 h and subsequently lysed and RNA was collected using the RNeasy kit (Qiagen). cDNA was synthesized from 1 μg of RNA using qScript cDNA supermix (Quanta). The relative mRNA levels of α1-PDX, MT1-MMP, MMP-2, and MMP-9 were assayed by qPCR using SensiFAST SYBR No-ROX Kit (FroggaBio) and the CFX Connect™ Real-Time PCR Detection System (Bio-Rad). mRNA levels were quantified by the ΔΔCT method and displayed as fold change relative to MDA-MB-231 cells. The level of GAPDH mRNA was used as the internal control. Primers used were as follows:
α1-PDX 5′-TGAAATCCTGGAGGGCCTGA 5′-AACC AGCCAGACAGCCAGCT.
MT1-MMP 5′-GCAGAAGTTTTACGGCTTGCA 5′-TCGAACATTGGCCTTGATCTC.
MMP-2 5′-AGCTCCCGGAAAAGATTGATG 5′-CAGG GTGCTGGCTGAGTAGAT.
MMP-9 5′-CCTGGAGACCTGAGAACCAATC 5′-GATTTCGACTCTCCACGCATCT.
GAPDH 5′-ACCCACTCCTCCACCTTTGA 5′-CTGT TGCTGTAGCCAAATTCGT.
Protein collection and immunoblotting
Cells were seeded and treated as with qPCR analysis. Cell lysates were collected and total protein concentration was determined. Protein aliquots (15 μg) were analyzed by immunoblotting with MT1-MMP and β-Actin primary antibodies incubated overnight at 4°C, followed by incubation with the appropriate secondary HRP-conjugated antibody for 1 h at room temperature. Primary antibodies used were: Human MT1-MMP (1:1000, AB6004, Millipore), pERK (1:2000, D13.14.4E, Cell Signalling Technology), total ERK1/2 (1:2000, 137F5, Cell Signalling Technology), and β-Actin (1:1000, C4, Santa Cruz Biotech). Secondary antibodies used were: goat anti-rabbit IgG (H + L) (Thermo Fisher) and goat anti-mouse IgG (H + L) (BioRad) HRP conjugates (1:10,000). Signal was detected using SuperSignal West Pico chemiluminescent substrate (Thermo Fisher). Images were captured using the Molecular Imager® ChemiDoc™ XRS System (BioRad). Quantitative densitometric analysis of immunoblots was performed using QuantityOne software (BioRad). Band intensity was obtained for each of MT1-MMP, β-Actin, pERK and total ERK1/2 from three independent biological experiments. The level of MT1-MMP pro-and active protein is normalized to the β-Actin signal. ERK1/2 activation is presented as a ratio between pERK and total ERK1/2 band intensities.
Firefly luciferase transcriptional activity assay
Cells were seeded at a density of 3.0 × 10 4 cells/mL in a 96-well culture plate (Corning) and incubated for 24 h. Following incubation, cells were transfected with luciferase reporter plasmids using Lipofectamine 2000 (Thermo Fisher), according to the manufacturer's instructions. Either 0.2 μg of mammalian 3xAP1pGL3 (Addgene Plasmid #40342) for AP1 transcription, or p1242 3xKB-L (Plasmid #26699) for NF-κB transcription were transfected into cells. 36 h later, cells were lysed and treated with Firefly Luciferase Glow Assay reagents (Thermo Fisher) according to the manufacturer's instructions. Luminescence was detected using Modulus™ II Microplate Multimode Reader and the GloMax®-Multi Detection System with Instinct® Software.
Transwell cell motility assays
The migratory and invasive potential of cells was measured using 24-well 8 μm pore transwell inserts (Corning). Cells were seeded at a density of 2.0 × 10 4 cells/mL on the upper chamber of the transwell insert in serum-free media and allowed to migrate (24 h) or invade (48 h) towards the bottom chamber containing DMEM/FBS, which served as the chemoattractant. Migration assays were performed with uncoated transwell inserts, while invasion assays were performed with transwell inserts coated with 20% Matrigel (BD Biosciences). Cells that migrated into the bottom chamber were fixed, stained, and quantified as per Marshall (2011) . Cells were fixed in 100% methanol and cells that did not move through the transwell were removed with a damp cotton swab. Fixed cells were stained with 0.5% crystal violet diluted in distilled water. To quantify cell migration, the stained transwells were individually de-stained in 33% acetic acid and the absorbance was read at 490 nm using the Microplate Reader Model 3550-UV (BioRad) as a correlative measurement of cell number, with the absorbance measure of control cells set to 100. To quantify cell invasion, residual stain was removed using a cotton swab and transwells were imaged using the Leica DM16000 B microscope with Hamamatsu camera controller (C10600) at 20× magnification. 15 images were taken per transwell and blindly quantified using ImageJ software (NIH, Bethesda), with the number of cells in the control samples being set as 100.
Three-dimensional cell culture
Cells were embedded in 50% Matrigel matrix (BD Biosciences) and examined for changes in invasive morphological features as described by Cvetković et al. (2014) .
35 mm glass-bottom cell culture dishes (MatTek) were coated with 50% Matrigel in serum-free medium. Once this layer solidified, 2.5 × 10 4 cells/mL seeded in 50% Matrigel in serum-free medium was placed above the initial layer, resulting in cells completely suspended in Matrigel. Cell colony morphology was monitored for 5 days using bright-field microscopy (Leica DM16000 B microscope with Leica DFC425 camera) at 10X magnification, capturing 50 μm zstack images (2 μm interval) taken at random locations across the matrix using Leica MMAF software (Metamorph®). To score cell morphology, several images representing a field of view at 20X magnification were blindly analyzed using ImageJ software (NIH, Bethesda). Protrusions were defined as thin extensions that emanated from a round cell colony. Our previous work has associated these structures with the actin cytoskeleton, the presence of MT1-MMP, and increased migration (Cepeda et al. 2016) . The number of protrusions on all cell colonies in an image was counted, with longer protrusions counted as multiples of the average protrusion length seen in that image to adjust for the heterogeneity in size observed as per Cepeda et al. 2016 . Disseminations were defined as small, round cells or particles immediately adjacent to a larger cell colony. We have shown that many of these particles do not contain nuclei and that such disseminations are associated with poor cell health and decreased migration (Cepeda et al. 2016) . The score represented the total number of protrusions or total number of disseminations for each treatment divided by the total number of colonies, which gave a final measurement of protrusions or disseminations per colony.
Avian embryo tumour vascularization assay
The invasion and vascularization of artificial Matrigel tumours of MDA-MB-231 cells and 231-PDX cells stably expressing ZsGreen were assessed in avian embryos. A superficial wound was introduced to the vasculature of the CAM of day 9 embryos and an artificial tumour composed of 10 μL of Matrigel (BD Bioscience) containing 5 × 10 5 cells was injected into the wound. 8 days post-implantation, tumours were examined using fluorescent stereomicroscopy to examine vascularization of the tumour shown by the presence of non-fluorescent CAM vessels within the zsGreen tumour. Vascularization was quantified as a binary measurement, indicated by the presence or absence of embryo-derived vasculature in a tumour, while total wound closure was used as a measure of tumour invasion, characterized by the presence of the tumour completely under the CAM (as per Cepeda et al. 2016 ).
Statistical analysis
GraphPad Prism version 6.0 was used for all statistical analysis and graphing. Data are presented as mean ± SEM, where all experiments comprised 3 or more biological replicates. Paired t-tests, one way ANOVA followed by independentsample t-tests, or chi-squared tests were used as indicated respectively in each figure legend. The different levels of significance are denoted as follows:
ns, p > 0.1; #, p ≤ 0.1; *, p ≤ 0.05; **, p ≤ 0.01; ***, p ≤ 0.001; ****, p ≤ 0.0001.
Results
Stable expression of α-PDX in MDA-MB-231 cells did not result in decreased MT1-MMP protein levels.
The α1-PDX gene contains a conserved R-X-X-R sequence, which unlike α1-antrypsin, specifically targets the activation site of furin and inhibits its protein convertase activity (Jean et al. 1998; Thomas 2002) . We generated clonal MDA-MB-231 cells (231-PDX) that stably express the α1-PDX gene at 4 fold increase (Fig. 1a) compared to MDA-MB-231 parental cells. While the MMP-2 mRNA level is downregulated to 0.3 fold, MMP-9 mRNA is upregulated 6 fold in 231-PDX ( Fig. 1c and d) . In contrast to chemical inhibition of furin (Cepeda et al. 2017a) , stable expression of α1-PDX in MDA-MB-231 cells did not decrease MT1-MMP protein levels. Instead, 231-PDX stable cells contained significantly higher levels of MT1-MMP mRNA (Fig. 1b) . Protein bands identified as MT1-MMP through the use of a well characterized antibody (Cepeda et al. 2016; Cepeda et al. 2017a,b) corroborated increased RNA levels by demonstrating increased protein levels (Fig. 2a) . While the level of pro-MT1-MMP did increase in 231-PDX cells (Fig. 2a and data not shown), densitometric quantification showed that the percentage of pro-MT1-MMP compared to total MT1-MMP protein levels did not differ between 231-PDX cells (21%), and MDA-MB-231 parental cells (21%) (Fig. 2b) . Taken together, these results suggest that stable expression of α1-PDX in MDA-MB-231 cells increased MT1-MMP, both at the transcript and total protein level, while the percentage of pro-MT1-MMP protein remained at about 21% of total MT1-MMP.
231-PDX stable cells mediated elevated MT1-MMP levels that were mirrored by MMP-9, and pERK, but not MMP-2 levels.
We previously showed that following chemical inhibition of furin, MMP activity, or MAPK signalling in MDA-MB-231 cells, all changed MT1-MMP levels that were mirrored by MMP-9 and pERK, but opposite to MMP-2 levels (Cepeda et al. 2017a ). In agreement with our previous work, analysis here revealed that 231-PDX stable cells contained significantly higher levels of MT1-MMP (Fig. 1b) and MMP-9 transcripts (Fig. 1d) , as well as pERK protein (Fig. 2a,c) , but significantly lower levels of MMP-2 transcripts (Fig. 1c) .
231-PDX stable cells demonstrated a decrease in NF-κB transcriptional activity.
To investigate possible mechanisms for the observed changes in MMP-2 and MMP-9 mRNA levels that are mediated by stable expression of α1-PDX in MDA-MB-231 cells, a luciferase gene reporter assay was conducted. Plasmids encoding luciferase under the regulation of either AP-1 or NF-κB promoters were transiently transfected into MDA-MB-231 parental cells and 231-PDX cells, and transcription was assayed after 36 h. Compared to MDA-MB-231 parental cells, 231-PDX cells showed a lower, but not significant change in AP-1 transcription (Fig. 3a) , whereas they showed a significant decrease in NF-κB transcriptional activity (Fig. 3b) .
231-PDX stable cells exhibited reduced migratory potential
Since 231-PDX stable cells displayed altered MT1-MMP, MMP-2, and MMP-9 transcript levels, and decreased NF-κB transcriptional activity, we investigated if these changes altered the migratory and invasive potential of these cells. The migratory potential of 231-PDX cells was examined through an uncoated transwell insert for 24 h. 231-PDX cells were significantly less migratory (by 19%) compared to MDA-MB-231 parental cells (Fig. 4a) . Invasion was measured through the use of a Matrigel-coated transwell insert for (Cepeda et al., 2016) . b) Corresponding densitometry quantification of pro-MT1-MMP amounts normalized to β-actin, and displayed as percent of total MT1-MMP protein represented by pro-MT1-MMP. c) Densitometry quantification of pERK normalized to total ERK levels. Data is displayed ± SEM and analyzed via t-test. ns = not significant; *, p ≤ 0.05 Fig. 1 Stable overexpression of α1-PDX in MDA-MB-231 cells altered MMP mRNA levels. qPCR was used to compare a) α1-PDX, b) MT1-MMP, c) MMP-2, and d) MMP-9 mRNA levels in parental MDA-MB-231 versus MDA-MB-231 cells stably transfected with α1-PDX. GAPDH was used as the internal control, and data is displayed as mRNA fold change ± SEM relative to parental and analyzed via t-test. ****, p ≤ 0.0001; ***, p ≤ 0.001 48 h, where the Matrigel acts as a barrier to simple migration. 231-PDX cells exhibited a slight decrease in invasion (p ≤ 0.1) compared to MDA-MB-231 parental cells (Fig. 4b) .
231-PDX stable cells exhibited morphological changes in 3D cell culture
In order to determine the effect of altered MT1-MMP activation levels on cell morphology, MDA-MB-231 parental cells and 231-PDX cells were grown in 50% Matrigel. By day 5, morphological differences were apparent between the cell lines where 231-PDX cells exhibited large round clumps of cells that lacked the long elongated cell structures seen in the parental MDA-MB-231 cells (Fig. 5a) . We have previously used Bprotrusions^as a quantifiable measure of cellular projections to demonstrate that MT1-MMP is associated with actin (needed for migration), but that with high levels of MT1-MMP, such actin protrusions decrease. Similarly, high levels of MT1-MMP are associated with cellular disseminations, many which lack a nucleus, and represent cells that are less healthy and less invasive (Cepeda et al. 2016; Cepeda et al. 2017a ). Here, 231-PDX cells had significantly less protrusions (~6 per colony) than MDA-MB-231 parental cells (~9 per colony) (Fig. 5b) . Alternatively, 231-PDX cells had significantly more disseminations per colony compared to MDA-MB-231 cells (Fig. 5c ).
231-PDX stable cells exhibited reduced vascularization and decreased wound closure within avian CAM
To assess the role of altering levels of MT1-MMP activation on tumour phenotype, artificial Matrigel tumours composed of ZsGreen tagged MDA-MB-231 parental cells or 231-PDX cells were injected into a wound in the CAM vasculature of 9-day old avian embryos and incubated for an additional 8 days. Following incubation, vascularization and wound closure of the tumour site was observed (Fig. 6a) . Vascularization was determined by the presence of chick vasculature within an excised tumour (as per Cepeda et al. 2016 , and data not shown). MDA-MB-231 tumours had high incidences of vascularization (19/21) while 231-PDX tumours had lower, but not significantly different, incidences of vascularization (9/12) (Fig. 6b) . Complete wound closure was defined as when the tumour was completely covered by chick tissue. MDA-MB-231 tumours had a high incidence of wound closure (13/16), while complete wound closure was significantly lower with 231-PDX tumours (3/8) (Fig. 6c) .
Discussion
We sought to elucidate the effects of stable α1-PDX overexpression on MT1-MMP levels and resulting cell behaviour in MDA-MB-231 cells. MT1-MMP has garnered much attention, in part due to its capability to increase the migratory capacity of cells through its ability to remodel the ECM, cell surface molecules, and facilitate signalling cascades (D'Alessio et al. 2008; Gingras et al. 2001; Mori et al. 2002; Rozanov et al. 2001; Zarrabi et al. 2011) . These wide-ranging functions are reflected by the complexities of MT1-MMP regulation: transcriptionally, by JNK, Akt, ERK1/2, and NF-κB (Han et al. 2001; Li et al. 2016; Yoshimoto et al. 2014; ) ; posttranscriptionally by MT1-MMP micro-RNAs, such as miR133a and miR-150-5p (Sakr et al. 2016) ; and posttranslationally, as pro-MT1-MMP needs to be activated. Furin has long been known to be important in regulating the level of active MT1-MMP (Coppola et al. 2008; Jean et al., 1998; Rozanov et al. 2001 ). However, furin seems to only partially contribute to the activation of pro-MT1-MMP (Jean et al. 1998; Otto et al., 2016) , and other players working in concert with furin may also be necessary, including the nonreceptor tyrosine kinase c-Src (Shi et al. 2012) , Golgi adapter protein GRASP55 (Roghi et al., 2010) , and even mechanosensitive stress events (Kang et al. 2015) .
Using MCF-7 cells (which natively lack MT1-MMP), we have shown that non-physiologically high levels of MT1-MMP protein (that result following transient transfection) may not be functionally meaningful. By creating stable cell lines, we demonstrated that a moderate (10 fold) increase in MT1-MMP levels was most potent with respect to changes in pERK signaling, cell survival, and cell migration and invasion (Cepeda et al. 2016 ). We observed a consistent pattern when these stable cells, or MDA-MB-231 cells (which naturally express MT1-MMP), were treated with inhibitors to furin, MMP activity, and MAPK signalling: high levels of active MT1-MMP, pERK, and MMP-9, but low levels of MMP-2 (Cepeda et al. 2016; Cepeda et al. 2017a ).
Here we created MDA-MB-231 cells that stably express moderate levels of α1-PDX. This stable expression of α1-PDX resulted in increased expression of MT1-MMP and MMP-9, but decreased MMP-2 mRNA, and increased levels of pERK ( Fig. 1 and 2) , in a pattern identical to that seen in our MCF-7 cells treated with inhibitors that impinge on MT1-MMP function (Cepeda et al. 2017a) . As MT1-MMP can facilitate signalling through the MAPK pathway, elevation of MT1-MMP levels followed by increased levels of pERK is not surprising. However, the consistent pattern of increased MMP-9, but decreased MMP-2 mRNA, is intriguing.
Through the inhibition of furin, α1-PDX should result in a decrease in the level of active MT1-MMP protein, and perhaps a proportional increase in pro-MT1-MMP. However, in our study, stable α1-PDX expression increased both MT1-MMP transcripts as well as total protein levels (Fig. 1b, 2a , and data not shown). This MT1-MMP increase following furin inhibition or α1-PDX overexpression has been demonstrated previously (Bassi et al. 2001; Yana and Weiss 2000) . Cells have an innate required level of MT1-MMP -with different cell types having different levels depending on their functions. This level of MT1-MMP is part of a native network with pERK, MMP-2, MMP-9, and likely other players, that are all modulated in tandem in a particular cell type. Here, with α1-PDX, while overall MT1-MMP protein levels did increase, it is interesting to note that the percentage of total MT1-MMP protein represented by pro-MT1-MMP did not Means are presented ± SEM, and were compared using one-way ANOVA; with statistical differences seen as follows: for protrusions; days 2 and 5, p ≤ 0.01; days 3 and 4, p ≤ 0.0001; disseminations: days 2-4, p ≤ 0.05; day 5, p ≤ 0.01 change -remaining at about 21% (Fig. 2b) Despite the expression of α1-PDX and its expected effect to increase the level of pro-MT1-MMP, the cells compensate by increasing overall MT1-MMP levels to maintain the pro-MT1-MMP levels at 21%. A similar mechanism, though likely at a different threshold level, may also explain the increase of MT1-MMP levels seen in other cell types (head and neck squamous carcinomas, COS-1, HT-1080, and LoVo cells; Yana and Weiss 2000; Bassi et al. 2001 ) treated with α1-PDX.
Altering MT1-MMP function can be associated with altered cell movement. But this relationship is cell type specific. We, and others, have demonstrated that MT1-MMP can modulate pERK levels. In our previous work with MCF-7 cells, optimal (moderate) levels of active MT1-MMP result in high pERK levels and high cell migration that is mitigated by pERK inhibition (Cepeda et al. 2016) . Here, however, elevated MT1-MMP and elevated pERK levels resulted in reduced migration. This is perhaps because unlike MCF-7 cells, where increased MT1-MMP levels resulted in increased levels of transcription by NF-κB (Cepeda et al. 2017b) , here MDA-MB-231 cells with increased MT1-MMP levels resulted in decreased levels of transcription by NF-κB (Fig. 3) . While the mechanism is not known, there are reports of direct MT1-MMP modulation of NF-kB signalling through PI3Kδ signalling (Wong et al. 2016) , and several studies have demonstrated an indirect link between NF-kB and MT1-MMP levels and cell migration (Kwiatkowska et al. 2011; Takino et al. 2016) .
We have also previously reported (Cepeda et al. 2016 ) that while high levels of MT1-MMP protein were associated with high levels of ECM degradation, this did not manifest in high levels of cell movement, nor invasion. Indeed, increasing MMP enzymatic activity did not impact cell movement as much as treatments that altered MT1-MMP induced pERK levels, such as the use of TIMP-2 as a ligand (Cepeda et al. 2016; Cepeda et al. 2017a) . Additionally, high levels of MT1-MMP altered cellular morphologies (reduced protrusions) and increased a-nuclear cell disseminations, as high levels of MT1-MMP were associated with poor cell survival (Cepeda et al. 2016; Cepeda et al. 2017a ). Here we demonstrate that elevated levels of MT1-MMP and MMP-9 following α1-PDX treatment reduced both cell migration and cell invasion (Fig.  4) . In addition, these elevated MT1-MMP and MMP-9 levels resulted in cellular morphologies not conducive to movement. When examined in 3D culture, 231-PDX cells contained fewer membrane extensions that are fundamental to cell movement, while also fragmenting (Fig. 5) . These in vitro cell movement limitations were corroborated in vivo using a chick CAM assay. When parental MDA-MD-231 cells were placed in a wound on the chick CAM, this resulted in the recruitment of vasculature into the tumour, as well as movement of the tumour into the chick tissue, such that there is complete wound closure (Fig. 6) . Parental MDA-MB-231 cells had very high degrees of vascularization (19/21) and wound closure (13/16). The 231-PDX cells had a reduced, but not significantly lower, frequency of vascularization (9/12), and a significantly lower frequency of wound closure (3/8). Changes in vascularization and wound closure require both ECM remodelling activity as well as changes in cell morphology and migration. Such coordination of ECM remodelling and cell morphology can be coordinated by MT1-MMP. As expression of α1-PDX should inhibit pro-MT1-MMP activation, a decrease in such cell movement events is perhaps not surprising. However, it should be noted that decreases in tumour progression may not necessarily be directly related to decreased levels of active MT1-MMP. Previously we saw that altering MT1-MMP levels via MMP inhibition (BB-94), MT1-MMP activation (furin inhibitor), or pERK signalling (U0126) all resulted in the same pattern -levels of MT1-MMP, MMP-9 and pERK always together, and opposite to that of MMP-2 (Cepeda et al. 2016; Cepeda et al. 2017b) . Thus, it is not the absolute level of MT1-MMP (indeed of any MMP) that is predictive of the invasive or migratory potential of a cell, but it is the coordinated actions of several factors that work in concert to impact numerous aspects of cellular function.
This work highlights the conservation of the network of molecules through which MT1-MMP functions, particularly its association with pERK, MMP-9, and MMP-2, and also reveals differences between cell types when MT1-MMP function is altered, as these cells try to maintain innate MT1-MMP protein networks and related signalling pathways.
